21 Cosmeceuticals
Buch
Herausgeber: Bae, Yoon-Soo Cindy; Ciocon, David H.
Titel: Procedural Dermatology: Postresidency and Fellowship Compendium, Volume 2
Print ISBN: 9783132424074; Online ISBN: 9783132437142; Buch-DOI: 10.1055/b000000254
1. Edition © 2023. Thieme. All rights reserved.
Georg Thieme Verlag KG, Stuttgart,
Fachgebiete: Dermatologie;Allergologie
Thieme Clinical Collections (English Language)
Summary
This chapter discusses the mechanism, stability, topical penetration, and supporting clinical evidence of common cosmeceutical ingredients. The stability and penetration data for these ingredients were gathered under controlled laboratory conditions. Given these products will be exposed to oxygen during application and may be stored in nonideal conditions, the shelf lives are likely lower than advertised. Use of niacin, the peptide palmitoyl-lysine-threonine-threonine-lysine-serine (Pal-KTTKS), and some growth factors in clinical trials produced only small improvements in wrinkles, so their costs may outweigh the benefits. Oral collagen may improve wrinkles based on preliminary evidence, but over-the-counter products are diverse and may not have adequate quantity of active collagen peptides. Two retinoid derivatives, retinaldehyde and retinol, demonstrated more substantial antiwrinkle effects, but their efficacy may still be lower than prescription retinoids. On the contrary, retinoid esters were not effective in reducing wrinkles but can concentrate in the epidermis, offering protection from ultraviolet (UV) induced deoxyribonucleic acid (DNA) damage. Other agents that were efficacious in reducing photodamage include DNA repair enzymes and the antioxidants, vitamin C, vitamin E, and ferulic acid, in combination. These agents that protect the skin from DNA damage may be useful additions to moisturizers and sunscreens to reduce the risk of photoaging. Azelaic acid and hydroquinone both reduce hyperpigmentation in randomized, controlled trials and are recommended as first-line therapies. However, hydroquinone may be more beneficial in prescription formulations than over-the-counter products. Overall, some cosmeceuticals have evidence substantiating their claims, but many other product claims are unfounded. Patients may benefit from consulting their dermatologists for guidance on how to best treat their cosmetic needs rather than spending time and money determining which cosmeceuticals are effective.
Schlüsselwörter
cosmeceutical - topical penetration - retinoids - hydroquinone - kojic acid - tranexamic acid - DNA repair enzymes - oral collagen - azelaic acid - curcumin- 1 Draelos ZD. Cosmeceuticals: what’s real, what’s not.. Dermatol Clin 2019; 37 (1) 107-115 PubMed (PMID: 30466682)
- 2 Levin J, Momin SB. How much do we really know about our favorite cosmeceutical ingredients?. J Clin Aesthet Dermatol 2010; 3 (2) 22-41 PubMed (PMID: 20725560)
- 3 Babamiri K, Nassab R. Cosmeceuticals: the evidence behind the retinoids.. Aesthet Surg J 2010; 30 (1) 74-77 PubMed (PMID: 20442078)
- 4 Kedishvili NY. Retinoic acid synthesis and degradation.. Subcell Biochem 2016; 81: 127-161 PubMed (PMID: 27830503)
- 5 Sorg O, Antille C, Kaya G, Saurat J-H. Retinoids in cosmeceuticals.. Dermatol Ther 2006; 19 (5) 289-296 PubMed (PMID: 17014484)
- 6 Lee C-M. Fifty years of research and development of cosmeceuticals: a contemporary review.. J Cosmet Dermatol 2016; 15 (4) 527-539 PubMed (PMID: 27496663)
- 7 Ortonne J-P. Retinoid therapy of pigmentary disorders.. Dermatol Ther 2006; 19 (5) 280-288 PubMed (PMID: 17014483)
- 8 Sheth VM, Pandya AG. Melasma: a comprehensive update: part II.. J Am Acad Dermatol 2011; 65 (4) 699-714 PubMed (PMID: 21920242)
- 9 Stratigos AJ, Katsambas AD. The role of topical retinoids in the treatment of photoaging.. Drugs 2005; 65 (8) 1061-1072 PubMed (PMID: 15907143)
- 10 Creidi P, Vienne MP, Ochonisky S et al. Profilometric evaluation of photodamage after topical retinaldehyde and retinoic acid treatment.. J Am Acad Dermatol 1998; 39 (6) 960-965 PubMed (PMID: 9843009)
- 11 Green C, Orchard G, Cerio R, Hawk JL. A clinicopathological study of the effects of topical retinyl propionate cream in skin photoageing.. Clin Exp Dermatol 1998; 23 (4) 162-167 PubMed (PMID: 9894360)
- 12 Kang S, Duell EA, Fisher GJ et al. Application of retinol to human skin in vivo induces epidermal hyperplasia and cellular retinoid binding proteins characteristic of retinoic acid but without measurable retinoic acid levels or irritation.. J Invest Dermatol 1995; 105 (4) 549-556 PubMed (PMID: 7561157)
- 13 Veraldi S, Rossi LC, Barbareschi M. Are topical retinoids teratogenic?. G Ital Dermatol Venereol 2016; 151 (6) 700-705 PubMed (PMID: 27598619)
- 14 Shapiro L, Pastuszak A, Curto G, Koren G. Safety of first-trimester exposure to topical tretinoin: prospective cohort study.. Lancet 1997; 350 (9085) 1143-1144 PubMed (PMID: 9343507)
- 15 Loureiro KD, Kao KK, Jones KL et al. Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy.. Am J Med Genet A 2005; 136 (2) 117-121 PubMed (PMID: 15940677)
- 16 Jick SS, Terris BZ, Jick H. First trimester topical tretinoin and congenital disorders.. Lancet 1993; 341 (8854) 1181-1182 PubMed (PMID: 8098078)
- 17 Fu PP, Cheng S-H, Coop L et al. Photoreaction, phototoxicity, and photocarcinogenicity of retinoids.. J Environ Sci Health Part C Environ Carcinog Ecotoxicol Rev 2003; 21 (2) 165-197 PubMed (PMID: 15845224)
- 18 Higgins S, Wesley NO. Topical retinoids and cosmeceuticals: where is the scientific evidence to recommend products to patients?. Curr Dermatol Rep 2015; 4 (2) 56-62 (PMID: NOT_FOUND)
- 19 Duell EA, Kang S, Voorhees JJ. Unoccluded retinol penetrates human skin in vivo more effectively than unoccluded retinyl palmitate or retinoic acid.. J Invest Dermatol 1997; 109 (3) 301-305 PubMed (PMID: 9284094)
- 20 Saurat JH, Didierjean L, Masgrau E et al. Topical retinaldehyde on human skin: biologic effects and tolerance.. J Invest Dermatol 1994; 103 (6) 770-774 PubMed (PMID: 7798613)
- 21 O’Byrne SM, Blaner WS. Retinol and retinyl esters: biochemistry and physiology.. J Lipid Res 2013; 54 (7) 1731-1743 PubMed (PMID: 23625372)
- 22 Lupo MP. Antioxidants and vitamins in cosmetics.. Clin Dermatol 2001; 19 (4) 467-473 PubMed (PMID: 11535390)
- 23 Watson REB, Long SP, Bowden JJ, Bastrilles JY, Barton SP, Griffiths CEM. Repair of photoaged dermal matrix by topical application of a cosmetic “antiageing” product.. Br J Dermatol 2008; 158 (3) 472-477 PubMed (PMID: 18070204)
- 24 Antille C, Tran C, Sorg O, Carraux P, Didierjean L, Saurat J-H. Vitamin A exerts a photoprotective action in skin by absorbing ultraviolet B radiation.. J Invest Dermatol 2003; 121 (5) 1163-1167 PubMed (PMID: 14708621)
- 25 Kafi R, Kwak HS, Schumacher WE et al. Improvement of naturally aged skin with vitamin A (retinol).. Arch Dermatol 2007; 143 (5) 606-612 PubMed (PMID: 17515510)
- 26 Ho ET, Trookman NS, Sperber BR et al. A randomized, double-blind, controlled comparative trial of the anti-aging properties of non-prescription tri-retinol 1.1% vs. prescription tretinoin 0.025%.. J Drugs Dermatol 2012; 11 (1) 64-69 PubMed (PMID: 22206079)
- 27 Draelos ZD. Skin lightening preparations and the hydroquinone controversy.. Dermatol Ther 2007; 20 (5) 308-313 PubMed (PMID: 18045355)
- 28 Halder RM, Richards GM. Management of dyschromias in ethnic skin.. Dermatol Ther 2004; 17 (2) 151-157 PubMed (PMID: 15113282)
- 29 Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: a review of clinical trials.. J Am Acad Dermatol 2006; 55 (6) 1048-1065 PubMed (PMID: 17097400)
- 30 Gao X-H, Zhang L, Wei H, Chen H-D. Efficacy and safety of innovative cosmeceuticals.. Clin Dermatol 2008; 26 (4) 367-374 PubMed (PMID: 18691517)
- 31 Levitt J. The safety of hydroquinone: a dermatologist’s response to the 2006 Federal Register.. J Am Acad Dermatol 2007; 57 (5) 854-872 PubMed (PMID: 17467115)
- 32 Levin CY, Maibach H. Exogenous ochronosis. An update on clinical features, causative agents and treatment options.. Am J Clin Dermatol 2001; 2 (4) 213-217 PubMed (PMID: 11705248)
- 33 DeCaprio AP. The toxicology of hydroquinone--relevance to occupational and environmental exposure.. Crit Rev Toxicol 1999; 29 (3) 283-330 PubMed (PMID: 10379810)
- 34 Garcia A, Fulton Jr JE. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions.. Dermatol Surg 1996; 22 (5) 443-447 PubMed (PMID: 8634807)
- 35 Khezri K, Saeedi M, Morteza-Semnani K, Akbari J, Rostamkalaei SS. An emerging technology in lipid research for targeting hydrophilic drugs to the skin in the treatment of hyperpigmentation disorders: kojic acid-solid lipid nanoparticles.. Artif Cells Nanomed Biotechnol 2020; 48 (1) 841-853 PubMed (PMID: 32456476)
- 36 Wester RC, Melendres J, Hui X et al. Human in vivo and in vitro hydroquinone topical bioavailability, metabolism, and disposition.. J Toxicol Environ Health A 1998; 54 (4) 301-317 PubMed (PMID: 9638901)
- 37 Kim H, Choi J, Cho JK, Kim SY, Lee YS. Solid-phase synthesis of kojic acid-tripeptides and their tyrosinase inhibitory activity, storage stability, and toxicity.. Bioorg Med Chem Lett 2004; 14 (11) 2843-2846 PubMed (PMID: 15125944)
- 38 Yoshimura K, Sato K, Aiba-Kojima E et al. Repeated treatment protocols for melasma and acquired dermal melanocytosis.. Dermatol Surg 2006; 32 (3) 365-371 PubMed (PMID: 16640680)
- 39 Monteiro RC, Kishore BN, Bhat RM, Sukumar D, Martis J, Ganesh HK. A comparative study of the efficacy of 4% hydroquinone vs 0.75% kojic acid cream in the treatment of facial melasma.. Indian J Dermatol 2013; 58 (2) 157 PubMed (PMID: 23716817)
- 40 Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: a review of clinical trials.. J Am Acad Dermatol 2006; 55 (6) 1048-1065 PubMed (PMID: 17097400)
- 41 Fitton A, Goa KL. Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders.. Drugs 1991; 41 (5) 780-798 PubMed (PMID: 1712709)
- 42 Akamatsu H, Komura J, Asada Y, Miyachi Y, Niwa Y. Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases.. Arch Dermatol Res 1991; 283 (3) 162-166 PubMed (PMID: 1867478)
- 43 Nugrahani HN, Iskandarsyah , Harmita . Stability study of azelaic acid proethosomes with lyoprotectant as stabilizer.. J Adv Pharm Technol Res 2018; 9 (2) 61-64 PubMed (PMID: 30131939)
- 44 Täuber U, Weiss C, Matthes H. Percutaneous absorption of azelaic acid in humans.. Exp Dermatol 1992; 1 (4) 176-179 PubMed (PMID: 1365318)
- 45 Gasco MR, Gallarate M, Pattarino F. In vitro permeation of azelaic acid from viscosized microemulsions.. Int J Pharm 1991; 69 (3) 193-196 (PMID: NOT_FOUND)
- 46 Burchacka E, Potaczek P, Paduszyński P, Karłowicz-Bodalska K, Han T, Han S. New effective azelaic acid liposomal gel formulation of enhanced pharmaceutical bioavailability.. Biomed Pharmacother 2016; 83: 771-775 PubMed (PMID: 27484346)
- 47 Taraz M, Niknam S, Ehsani AH. Tranexamic acid in treatment of melasma: a comprehensive review of clinical studies.. Dermatol Ther (Heidelb) 2017; 30 (3) e12465 PubMed (PMID: 28133910)
- 48 Del Rosario E, Florez-Pollack S, Zapata Jr L et al. Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma.. J Am Acad Dermatol 2018; 78 (2) 363-369 PubMed (PMID: 28987494)
- 49 Bala HR, Lee S, Wong C, Pandya AG, Rodrigues M. Oral tranexamic acid for the treatment of melasma: a review.. Dermatol Surg 2018; 44 (6) 814-825 PubMed (PMID: 29677015)
- 50 Donnelly RF. Stability of tranexamic acid mouth rinse.. Int J Pharm Compd 2018; 22 (5) 412-416 PubMed (PMID: 30384339)
- 51 Vijayakumar A, Baskaran R, Yoo BK. Skin permeation and retention of topical bead formulation containing tranexamic acid.. J Cosmet Laser Ther 2017; 19 (1) 68-74 PubMed (PMID: 27762649)
- 52 Kanechorn Na Ayuthaya P, Niumphradit N, Manosroi A, Nakakes A. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial.. J Cosmet Laser Ther 2012; 14 (3) 150-154 PubMed (PMID: 22506692)
- 53 Ebrahimi B, Naeini FF. Topical tranexamic acid as a promising treatment for melasma.. J Res Med Sci 2014; 19 (8) 753-757 PubMed (PMID: 25422661)
- 54 Banihashemi M, Zabolinejad N, Jaafari MR, Salehi M, Jabari A. Comparison of therapeutic effects of liposomal tranexamic acid and conventional hydroquinone on melasma.. J Cosmet Dermatol 2015; 14 (3) 174-177 PubMed (PMID: 26177992)
- 55 Tanno O, Ota Y, Kitamura N, Katsube T, Inoue S. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier.. Br J Dermatol 2000; 143 (3) 524-531 PubMed (PMID: 10971324)
- 56 Hakozaki T, Minwalla L, Zhuang J et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer.. Br J Dermatol 2002; 147 (1) 20-31 PubMed (PMID: 12100180)
- 57 Bissett DL, Miyamoto K, Sun P, Li J, Berge CA. Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin.. Int J Cosmet Sci 2004; 26 (5) 231-238 PubMed (PMID: 18492135)
- 58 Otte N, Borelli C, Korting HC. Nicotinamide: biologic actions of an emerging cosmetic ingredient.. Int J Cosmet Sci 2005; 27 (5) 255-261 PubMed (PMID: 18492206)
- 59 Boonme P, Boonthongchuay C, Wongpoowarak W, Amnuaikit T. Evaluation of nicotinamide microemulsion on the skin penetration enhancement.. Pharm Dev Technol 2016; 21 (1) 116-120 PubMed (PMID: 25318786)
- 60 Feldmann RJ, Maibach HI. Absorption of some organic compounds through the skin in man.. J Invest Dermatol 1970; 54 (5) 399-404 PubMed (PMID: 4245370)
- 61 Navarrete-Solís J, Castanedo-Cázares JP, Torres-Álvarez B et al. A double-blind, randomized clinical trial of niacinamide 4% versus hydroquinone 4% in the treatment of melasma.. Dermatol Res Pract 2011; 2011: 379173 PubMed (PMID: 21822427)
- 62 Lin JY, Selim MA, Shea CR et al. UV photoprotection by combination topical antioxidants vitamin C and vitamin E.. J Am Acad Dermatol 2003; 48 (6) 866-874 PubMed (PMID: 12789176)
- 63 Pinnell SR, Yang H, Omar M et al. Topical L-ascorbic acid: percutaneous absorption studies.. Dermatol Surg 2001; 27 (2) 137-142 PubMed (PMID: 11207686)
- 64 Murray JC, Burch JA, Streilein RD, Iannacchione MA, Hall RP, Pinnell SR. A topical antioxidant solution containing vitamins C and E stabilized by ferulic acid provides protection for human skin against damage caused by ultraviolet irradiation.. J Am Acad Dermatol 2008; 59 (3) 418-425 PubMed (PMID: 18603326)
- 65 Geesin JC, Darr D, Kaufman R, Murad S, Pinnell SR. Ascorbic acid specifically increases type I and type III procollagen messenger RNA levels in human skin fibroblast.. J Invest Dermatol 1988; 90 (4) 420-424 PubMed (PMID: 3351329)
- 66 Tajima S, Pinnell SR. Ascorbic acid preferentially enhances type I and III collagen gene transcription in human skin fibroblasts.. J Dermatol Sci 1996; 11 (3) 250-253 PubMed (PMID: 8785178)
- 67 Chan AC. Partners in defense, vitamin E and vitamin C.. Can J Physiol Pharmacol 1993; 71 (9) 725-731 PubMed (PMID: 8313238)
- 68 Fitzpatrick RE, Rostan EF. Double-blind, half-face study comparing topical vitamin C and vehicle for rejuvenation of photodamage.. Dermatol Surg 2002; 28 (3) 231-236 PubMed (PMID: 11896774)
- 69 Tanaydin V, Conings J, Malyar M, van der Hulst R, van der Lei B. The role of topical vitamin E in scar management: a systematic review.. Aesthet Surg J 2016; 36 (8) 959-965 PubMed (PMID: 26977069)
- 70 Zduńska K, Dana A, Kolodziejczak A, Rotsztejn H. Antioxidant properties of ferulic acid and its possible application.. Skin Pharmacol Physiol 2018; 31 (6) 332-336 PubMed (PMID: 30235459)
- 71 Raschke T, Koop U, Düsing H-J et al. Topical activity of ascorbic acid: from in vitro optimization to in vivo efficacy.. Skin Pharmacol Physiol 2004; 17 (4) 200-206 PubMed (PMID: 15258452)
- 72 Stamford NPJ. Stability, transdermal penetration, and cutaneous effects of ascorbic acid and its derivatives.. J Cosmet Dermatol 2012; 11 (4) 310-317 PubMed (PMID: 23174055)
- 74 Austria R, Semenzato A, Bettero A. Stability of vitamin C derivatives in solution and topical formulations.. J Pharm Biomed Anal 1997; 15 (6) 795-801 PubMed (PMID: 9172105)
- 75 Keen MA, Hassan I. Vitamin E in dermatology.. Indian Dermatol Online J 2016; 7 (4) 311-315 PubMed (PMID: 27559512)
- 76 Alberts DS, Goldman R, Xu MJ et al. Disposition and metabolism of topically administered alpha-tocopherol acetate: a common ingredient of commercially available sunscreens and cosmetics.. Nutr Cancer 1996; 26 (2) 193-201 PubMed (PMID: 8875556)
- 77 Lin FH, Lin JY, Gupta RD et al. Ferulic acid stabilizes a solution of vitamins C and E and doubles its photoprotection of skin.. J Invest Dermatol 2005; 125 (4) 826-832 PubMed (PMID: 16185284)
- 78 Burke KE. Interaction of vitamins C and E as better cosmeceuticals.. Dermatol Ther 2007; 20 (5) 314-321 PubMed (PMID: 18045356)
- 79 Steenvoorden DPT, Beijersbergen van Henegouwen G. Protection against UV-induced systemic immunosuppression in mice by a single topical application of the antioxidant vitamins C and E.. Int J Radiat Biol 1999; 75 (6) 747-755 PubMed (PMID: 10405005)
- 80 Humbert PG, Haftek M, Creidi P et al. Topical ascorbic acid on photoaged skin. Clinical, topographical and ultrastructural evaluation: double-blind study vs. placebo.. Exp Dermatol 2003; 12 (3) 237-244 PubMed (PMID: 12823436)
- 81 Gupta SC, Prasad S, Kim JH et al. Multitargeting by curcumin as revealed by molecular interaction studies.. Nat Prod Rep 2011; 28 (12) 1937-1955 PubMed (PMID: 21979811)
- 82 Heng MCY. Curcumin targeted signaling pathways: basis for anti-photoaging and anti-carcinogenic therapy.. Int J Dermatol 2010; 49 (6) 608-622 PubMed (PMID: 20618464)
- 83 Cheng AL, Hsu CH, Lin JK et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.. Anticancer Res 2001; 21 (Suppl. 4B) 2895-2900 PubMed (PMID: 11712783)
- 84 Sommerfeld B. Randomised, placebo-controlled, double-blind, split-face study on the clinical efficacy of Tricutan on skin firmness.. Phytomedicine 2007; 14 (11) 711-715 PubMed (PMID: 17923398)
- 85 Ablon G, Kogan S. A six-month, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of a nutraceutical supplement for promoting hair growth in women with self-perceived thinning hair.. J Drugs Dermatol 2018; 17 (5) 558-565 PubMed (PMID: 29742189)
- 86 Vaughn AR, Branum A, Sivamani RK. Effects of turmeric (Curcuma longa) on skin health: a systematic review of the clinical evidence.. Phytother Res 2016; 30 (8) 1243-1264 PubMed (PMID: 27213821)
- 87 Kloepper JE, Ernst N, Krieger K et al. NF-κB activity is required for anagen maintenance in human hair follicles in vitro.. J Invest Dermatol 2014; 134 (7) 2036-2038 PubMed (PMID: 24518172)
- 88 Gupta S, Ghosh S, Gupta S, Sakhuja P. Effect of curcumin on the expression of p53, transforming growth factor-β, and inducible nitric oxide synthase in oral submucous fibrosis: a pilot study.. J Investig Clin Dent 2017; 8 (4) PubMed (PMID: 27989010)
- 89 Seiberg M, Marthinuss J, Stenn KS. Changes in expression of apoptosis-associated genes in skin mark early catagen.. J Invest Dermatol 1995; 104 (1) 78-82 PubMed (PMID: 7798646)
- 90 Shishodia S. Molecular mechanisms of curcumin action: gene expression.. Biofactors 2013; 39 (1) 37-55 PubMed (PMID: 22996381)
- 91 Salem M, Rohani S, Gillies ER. Curcumin, a promising anti-cancer therapeutic: a review of its chemical properties, bioactivity and approaches to cancer cell delivery.. RSC Advances 2014; 4 (21) 10815-10829 (PMID: NOT_FOUND)
- 92 Wang Y-J, Pan M-H, Cheng A-L et al. Stability of curcumin in buffer solutions and characterization of its degradation products.. J Pharm Biomed Anal 1997; 15 (12) 1867-1876 PubMed (PMID: 9278892)
- 93 Liu W, Zhai Y, Heng X et al. Oral bioavailability of curcumin: problems and advancements.. J Drug Target 2016; 24 (8) 694-702 PubMed (PMID: 26942997)
- 94 Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers.. Planta Med 1998; 64 (4) 353-356 PubMed (PMID: 9619120)
- 95 Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials.. Cell Mol Life Sci 2008; 65 (11) 1631-1652 PubMed (PMID: 18324353)
- 96 Heng MC, Song MK, Harker J, Heng MK. Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters.. Br J Dermatol 2000; 143 (5) 937-949 PubMed (PMID: 11069500)
- 97 Yarosh D, Alas LG, Yee V et al. Pyrimidine dimer removal enhanced by DNA repair liposomes reduces the incidence of UV skin cancer in mice.. Cancer Res 1992; 52 (15) 4227-4231 PubMed (PMID: 1638536)
- 98 Kabir Y, Seidel R, Mcknight B, Moy R. DNA repair enzymes: an important role in skin cancer prevention and reversal of photodamage–a review of the literature.. J Drugs Dermatol 2015; 14 (3) 297-303 PubMed (PMID: 25738852)
- 99 Cafardi JA, Elmets CA. T4 endonuclease V: review and application to dermatology.. Expert Opin Biol Ther 2008; 8 (6) 829-838 PubMed (PMID: 18476794)
- 100 Berardesca E, Bertona M, Altabas K, Altabas V, Emanuele E. Reduced ultraviolet-induced DNA damage and apoptosis in human skin with topical application of a photolyase-containing DNA repair enzyme cream: clues to skin cancer prevention.. Mol Med Rep 2012; 5 (2) 570-574 PubMed (PMID: 22086236)
- 101 Yarosh D, Klein J, O’Connor A, Hawk J, Rafal E, Wolf P, . Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study.. Lancet 2001; 357 (9260) 926-929 PubMed (PMID: 11289350)
- 102 Yarosh D, Bucana C, Cox P, Alas L, Kibitel J, Kripke M. Localization of liposomes containing a DNA repair enzyme in murine skin.. J Invest Dermatol 1994; 103 (4) 461-468 PubMed (PMID: 7930668)
- 103 Robinson LR, Fitzgerald NC, Doughty DG, Dawes NC, Berge CA, Bissett DL. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin.. Int J Cosmet Sci 2005; 27 (3) 155-160 PubMed (PMID: 18492182)
- 104 Katayama K, Armendariz-Borunda J, Raghow R, Kang AH, Seyer JM. A pentapeptide from type I procollagen promotes extracellular matrix production.. J Biol Chem 1993; 268 (14) 9941-9944 PubMed (PMID: 8486721)
- 105 Mulder GD, Patt LM, Sanders L et al. Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper.. Wound Repair Regen 1994; 2 (4) 259-269 PubMed (PMID: 17147644)
- 106 Badenhorst T, Svirskis D, Wu Z. Physicochemical characterization of native glycyl-l-histidyl-l-lysine tripeptide for wound healing and anti-aging: a preformulation study for dermal delivery.. Pharm Dev Technol 2016; 21 (2) 152-160 PubMed (PMID: 25384620)
- 107 Miller TR, Wagner JD, Baack BR, Eisbach KJ. Effects of topical copper tripeptide complex on CO₂ laser-resurfaced skin.. Arch Facial Plast Surg 2006; 8 (4) 252-259 PubMed (PMID: 16847171)
- 108 Mehta RC, Fitzpatrick RE. Endogenous growth factors as cosmeceuticals.. Dermatol Ther 2007; 20 (5) 350-359 PubMed (PMID: 18045360)
- 109 Gold MH, Goldman MP, Biron J. Human growth factor and cytokine skin cream for facial skin rejuvenation as assessed by 3D in vivo optical skin imaging.. J Drugs Dermatol 2007; 6 (10) 1018-1023 PubMed (PMID: 17966179)
- 110 Mehta RC, Smith SR, Grove GL et al. Reduction in facial photodamage by a topical growth factor product.. J Drugs Dermatol 2008; 7 (9) 864-871 PubMed (PMID: 19112801)
- 111 Lyons A, Stoll J, Moy R. A randomized, double-blind, placebo-controlled, split-face study of the efficacy of topical epidermal growth factor for the treatment of melasma.. J Drugs Dermatol 2018; 17 (9) 970-973 PubMed (PMID: 30235384)
- 112 Choi YL, Park EJ, Kim E, Na DH, Shin Y-H. Dermal stability and in vitro skin permeation of collagen pentapeptides (KTTKS and palmitoyl-KTTKS).. Biomol Ther (Seoul) 2014; 22 (4) 321-327 PubMed (PMID: 25143811)
- 113 Hostynek JJ, Dreher F, Maibach HI. Human skin retention and penetration of a copper tripeptide in vitro as function of skin layer towards anti-inflammatory therapy.. Inflamm Res 2010; 59 (11) 983-988 PubMed (PMID: 20703511)
- 114 Fu JJJ, Hillebrand GG, Raleigh P et al. A randomized, controlled comparative study of the wrinkle reduction benefits of a cosmetic niacinamide/peptide/retinyl propionate product regimen vs. a prescription 0.02% tretinoin product regimen.. Br J Dermatol 2010; 162 (3) 647-654 PubMed (PMID: 20374604)
- 115 Choi FD, Sung CT, Juhasz MLW, Mesinkovsk NA. Oral collagen supplementation: a systematic review of dermatological applications.. J Drugs Dermatol 2019; 18 (1) 9-16 PubMed (PMID: 30681787)
- 116 Kawaguchi T, Nanbu PN, Kurokawa M. Distribution of prolylhydroxyproline and its metabolites after oral administration in rats.. Biol Pharm Bull 2012; 35 (3) 422-427 PubMed (PMID: 22382331)
- 117 Proksch E, Schunck M, Zague V, Segger D, Degwert J, Oesser S. Oral intake of specific bioactive collagen peptides reduces skin wrinkles and increases dermal matrix synthesis.. Skin Pharmacol Physiol 2014; 27 (3) 113-119 PubMed (PMID: 24401291)